Literature DB >> 12925274

Structure of the semaphorin-3A receptor binding module.

Alexander Antipenko1, Juha-Pekka Himanen, Klaus van Leyen, Vincenzo Nardi-Dei, Jacob Lesniak, William A Barton, Kanagalaghatta R Rajashankar, Min Lu, Claudia Hoemme, Andreas W Püschel, Dimitar B Nikolov.   

Abstract

The semaphorins are a large group of extracellular proteins involved in a variety of processes during development, including neuronal migration and axon guidance. Their distinctive feature is a conserved 500 amino acid semaphorin domain, a ligand-receptor interaction module also present in plexins and scatter-factor receptors. We report the crystal structure of a secreted 65 kDa form of Semaphorin-3A (Sema3A), containing the full semaphorin domain. Unexpectedly, the semaphorin fold is a variation of the beta propeller topology. Analysis of the Sema3A structure and structure-based mutagenesis data identify the neuropilin binding site and suggest a potential plexin interaction site. Based on the structure, we present a model for the initiation of semaphorin signaling and discuss potential similarities with the signaling mechanisms of other beta propeller cell surface receptors, such as integrins and the LDL receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925274     DOI: 10.1016/s0896-6273(03)00502-6

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  77 in total

Review 1.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 2.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1.

Authors:  Heli Liu; Z Sean Juo; Ann Hye-Ryong Shim; Pamela J Focia; Xiaoyan Chen; K Christopher Garcia; Xiaolin He
Journal:  Cell       Date:  2010-08-19       Impact factor: 41.582

4.  Class A Plexins Are Organized as Preformed Inactive Dimers on the Cell Surface.

Authors:  Morgan Marita; Yuxiao Wang; Megan J Kaliszewski; Kevin C Skinner; William D Comar; Xiaojun Shi; Pranathi Dasari; Xuewu Zhang; Adam W Smith
Journal:  Biophys J       Date:  2015-11-03       Impact factor: 4.033

5.  When monomers are preferred: a strategy for the identification and disruption of weakly oligomerized proteins.

Authors:  Yufeng Tong; David Hughes; Lisa Placanica; Matthias Buck
Journal:  Structure       Date:  2005-01       Impact factor: 5.006

Review 6.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

7.  Binding of Rac1, Rnd1, and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain.

Authors:  Yufeng Tong; Preeti Chugha; Prasanta K Hota; Rebecca S Alviani; Mei Li; Wolfram Tempel; Limin Shen; Hee-Won Park; Matthias Buck
Journal:  J Biol Chem       Date:  2007-10-04       Impact factor: 5.157

Review 8.  Getting neural circuits into shape with semaphorins.

Authors:  R Jeroen Pasterkamp
Journal:  Nat Rev Neurosci       Date:  2012-08-16       Impact factor: 34.870

Review 9.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

10.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.